Redwood City, CA, United States of America

Xian Wu

This inventor holds 2 USPTO granted patents. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xian Wu. Retrieved from https://idiyas.com/inventor/xian-wu-3rdia2n2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 210(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xian Wu: Innovator in cDNA Expression Vector Libraries

Introduction

Xian Wu is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of cDNA expression vector libraries. With a total of 2 patents, his work has implications for various applications in genetic research and therapeutic development.

Latest Patents

Xian Wu's latest patents focus on directionally cloned random cDNA expression vector libraries. The first patent provides random cDNA expression vector libraries that comprise expression vectors with random cDNAs positioned in both sense and antisense orientations. This innovation includes methods for producing these libraries through directional cloning of random cDNAs. Additionally, the patent outlines methods for using these libraries to screen for agents capable of modulating cell phenotype in desirable ways.

Career Highlights

Xian Wu is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research in biotechnology. His work at Rigel Pharmaceuticals has allowed him to collaborate with other experts in the field, enhancing the impact of his inventions.

Collaborations

Some of Xian Wu's notable coworkers include Mary Shen and Simon Yu. Their collaborative efforts contribute to the innovative environment at Rigel Pharmaceuticals, fostering advancements in biotechnology.

Conclusion

Xian Wu's contributions to the field of biotechnology through his patents on cDNA expression vector libraries demonstrate his commitment to innovation. His work not only advances scientific understanding but also has the potential to lead to significant therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…